Susana Sainz de la Maza Selected Research

teriflunomide

1/2019

Teriflunomide induces a tolerogenic bias in blood immune cells of MS patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Susana Sainz de la Maza Research Topics

Disease

10	Multiple Sclerosis 08/2022 - 01/2016
2	Progressive Multifocal Leukoencephalopathy 03/2022 - 03/2019
2	Lymphopenia (Lymphocytopenia) 03/2022 - 03/2019
2	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 04/2021 - 01/2021
2	Myelitis 01/2018 - 04/2016
2	Ischemic Stroke 02/2014 - 01/2014
1	Inflammation (Inflammations) 01/2022
1	Chronic Progressive Multiple Sclerosis 01/2022
1	COVID-19 04/2021
1	Neoplasms (Cancer) 04/2021
1	Relapsing-Remitting Multiple Sclerosis 01/2021
1	Nervous System Diseases (Neurological Disorders) 01/2018
1	Meningitis 01/2018
1	Central Nervous System Infections (Central Nervous System Infection) 01/2018
1	Central Nervous System Diseases (CNS Diseases) 01/2018
1	Encephalitis (Encephalitis, Rasmussen) 01/2018
1	Transverse Myelitis (Necrotizing Myelitis) 04/2016
1	Ganglion Cysts (Ganglion) 01/2016
1	Arterial Occlusive Diseases (Arterial Occlusive Disease) 02/2014
1	Neurologic Manifestations (Neurological Manifestations) 02/2014
1	Hematuria 01/2014
1	Cerebral Hemorrhage 01/2014
1	Metrorrhagia (Spotting) 01/2014
1	Stroke (Strokes) 01/2014
1	Hemorrhage 01/2014

Drug/Important Bio-Agent (IBA)

6	Dimethyl FumarateIBA 03/2022 - 03/2019
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2021
2	LipidsIBA 01/2020 - 01/2016
2	Oligoclonal BandsIBA 01/2020 - 01/2016
2	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 04/2016
2	Foscarnet FDA LinkGeneric 01/2018 - 04/2016
1	ocrelizumabIBA 01/2022
1	SteroidsIBA 04/2021
1	Adrenal Cortex Hormones (Corticosteroids)IBA 04/2021
1	Immunoglobulins (Immunoglobulin)IBA 01/2021
1	Immunoglobulin M (IgM)IBA 01/2021
1	Alemtuzumab (Campath)FDA Link 01/2021
1	AntibodiesIBA 01/2020
1	Natalizumab (Tysabri)FDA Link 01/2020
1	Dihydroorotate DehydrogenaseIBA 01/2019
1	pyrimidineIBA 01/2019
1	EnzymesIBA 01/2019
1	teriflunomideIBA 01/2019
1	Ganciclovir (Cytovene)FDA LinkGeneric 01/2018
1	Methylprednisolone FDA LinkGeneric 04/2016
1	Retinaldehyde (Retinal)IBA 01/2016
1	AutoantibodiesIBA 01/2016
1	Warfarin (Coumadin)FDA LinkGeneric 01/2014
1	Dabigatran FDA Link 01/2014

Therapy/Procedure

5	Therapeutics 08/2022 - 02/2014
2	Artificial Respiration (Mechanical Ventilation) 04/2021 - 01/2021
1	Aftercare (After-Treatment) 03/2022
1	Precision Medicine 01/2020
1	Thrombectomy 02/2014